Morgan Stanley
IGIC icon

Morgan Stanley’s International General Insurance IGIC Stock Holding History

Morgan Stanley’s Portfolio IGIC Stock Details IGIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$997K Sell
41,154
-2,879
-7% -$70.5K ﹤0.01% 5143
2025
Q4 		$1.1M Buy
44,033
+1,362
+3% +$32K ﹤0.01% 5134
2025
Q3 		$990K Sell
42,671
-15,387
-27% -$369K ﹤0.01% 5184
2025
Q2 		$1.39M Sell
58,058
-2,081
-3% -$49.4K ﹤0.01% 4929
2025
Q1 		$1.58M Sell
60,139
-1,244
-2% -$31.5K ﹤0.01% 4756
2024
Q4 		$1.46M Buy
61,383
+8,564
+16% +$195K ﹤0.01% 4897
2024
Q3 		$1M Buy
52,819
+13,489
+34% +$227K ﹤0.01% 5038
2024
Q2 		$551K Buy
39,330
+10,713
+37% +$150K ﹤0.01% 5249
2024
Q1 		$387K Sell
28,617
-28,443
-50% -$370K ﹤0.01% 5423
2023
Q4 		$735K Buy
57,060
+40,630
+247% +$472K ﹤0.01% 5451
2023
Q3 		$185K Buy
16,430
+7,300
+80% +$73.6K ﹤0.01% 5617
2023
Q2 		$81.6K Buy
9,130
+5,600
+159% +$48.3K ﹤0.01% 6033
2023
Q1 		$29.3K Sell
3,530
-800
-18% -$6.62K ﹤0.01% 6486
2022
Q4 		$34.6K Hold
4,330
– – ﹤0.01% 6448
2022
Q3 		$34K Sell
4,330
-4,195
-49% -$31.9K ﹤0.01% 6571
2022
Q2 		$66K Sell
8,525
-5,048
-37% -$38.7K ﹤0.01% 6481
2022
Q1 		$107K Sell
13,573
-4,036
-23% -$30.9K ﹤0.01% 6262
2021
Q4 		$143K Buy
17,609
+3,611
+26% +$29.6K ﹤0.01% 6245
2021
Q3 		$117K Sell
13,998
-2,373
-14% -$21.8K ﹤0.01% 6283
2021
Q2 		$153K Buy
16,371
+4,696
+40% +$39.7K ﹤0.01% 6149
2021
Q1 		$95K Sell
11,675
-100
-0.8% -$782 ﹤0.01% 6049
2020
Q4 		$95K Sell
11,775
-200
-2% -$1.52K ﹤0.01% 5932
2020
Q3 		$86K Buy
11,975
+1,420
+13% +$9.54K ﹤0.01% 5500
2020
Q2 		$73K Buy
+10,555
New +$68.3K ﹤0.01% 5534
2020
Q1 		– Sell
-1,203
Closed -$13K – 6623
2019
Q4 		$13K Buy
+1,203
New +$12.5K ﹤0.01% 6197
2019
Q3 		– Sell
-958
Closed -$10K – 6683
2019
Q2 		$10K Buy
958
+594
+163% +$6.01K ﹤0.01% 6128
2019
Q1 		$4K Sell
364
-36
-9% -$359 ﹤0.01% 6356
2018
Q4 		$4K Buy
400
+223
+126% +$2.17K ﹤0.01% 6333
2018
Q3 		$2K Sell
177
-46
-21% -$444 ﹤0.01% 6573
2018
Q2 		$2K Buy
+223
New +$2.14K ﹤0.01% 6543

Other funds holding IGIC

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
DDPIC
Deroy & Devereaux Private Investment Counsel Bloomfield Hills, Michigan $2.4B AUM 57.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Morgan Stanley's IGIC Position: Q1 2026 in Review

Morgan Stanley reduced its International General Insurance (IGIC) stake by 6.5% in Q1 2026, selling an estimated $70.5K and leaving 41,154 shares worth $997K. The position accounts for ﹤0.01% of the portfolio, ranked #5143.

Morgan Stanley first reported a position in IGIC in Q2 2018 and has held it in 30 quarters since. The position peaked at $1.58M in Q1 2025. 62 funds tracked by Wall St. Rank hold IGIC as of Q1 2026.

  • Morgan Stanley held 41,154 shares of International General Insurance worth $997K as of Q1 2026.
  • Morgan Stanley sold 2,879 International General Insurance shares in Q1 2026, an estimated $70.5K.
  • International General Insurance made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5143 holding.
  • Morgan Stanley first reported a position in International General Insurance in Q2 2018 and has held it in 30 quarters since.
  • Morgan Stanley's International General Insurance position peaked at $1.58M in Q1 2025.
  • 62 funds tracked by Wall St. Rank held International General Insurance as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.